Related Experiment Video
Updated: Apr 15, 2026

Immunofluorescence Imaging of DNA Damage and Repair Foci in Human Colon Cancer Cells
Published on: June 9, 2020
Rap1 is indispensable for TRF2 function in etoposide-induced DNA damage response in gastric cancer cell line
1Department of Neurology, Second Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Abstract:
The telomeric protein TRF2, involving in telomeric and extratelomeric DNA damage response, has been previously reported to facilitate multidrug resistance (MDR) in gastric cancer cells by interfering ATM-dependent DNA damage response induced by anticancer drugs. Rap1 is the TRF2-interacting protein in the shelterin complex. Complex formation between Rap1 and TRF2 is essential for their function in telomere and end protection. Here we focus on the effects of Rap1 on TRF2 function in DNA damage response induced by anticancer drugs. Both Rap1 and TRF2 expression were upregulated in SGC7901 and its MDR variant SGC7901/VCR after etoposide treatment, which was more marked in SGC7901/VCR than in SGC7901. Rap1 silencing by siRNA in SGC7901/VCR partially reversed the etoposide resistance. And Rap1 silencing partially reversed the TRF2-mediated resistance to etoposide in SGC7901. Rap1 silencing did not affect the TRF2 upregulation induced by etoposide, but eliminated the inhibition effect of TRF2 on ATM expression and ATM phosphorylation at serine 1981 (ATM pS1981). Furthermore, phosphorylation of ATM targets, including γH2AX and serine 15 (S15) on p53, were increased in Rap1 silencing cells in response to etoposide. Thus, we confirm that Rap1, interacting with TRF2 in the shelterin complex, also has an important role in TRF2-mediated DNA damage response in gastric cancer cells treated by etoposide.
Insights
Rap1, a protein interacting with TRF2, plays a key role in gastric cancer cells' resistance to etoposide. Silencing Rap1 reverses this resistance by restoring ATM-dependent DNA damage response pathways.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Telomeric repeat-binding factor 2 (TRF2) is implicated in DNA damage response and multidrug resistance (MDR) in gastric cancer.
- Rap1 is a TRF2-interacting protein crucial for telomere protection.
- The role of Rap1 in TRF2-mediated drug resistance remains unclear.
Purpose of the Study:
- To investigate the effect of Rap1 on TRF2 function in DNA damage response induced by anticancer drugs.
- To elucidate the mechanism by which Rap1 influences etoposide resistance in gastric cancer cells.
Main Methods:
- Utilized gastric cancer cell lines (SGC7901 and SGC7901/VCR) treated with etoposide.
- Employed siRNA to silence Rap1 expression.
- Assessed protein expression and phosphorylation levels of TRF2, Rap1, ATM, γH2AX, and p53.
Main Results:
- Both Rap1 and TRF2 expression increased following etoposide treatment, notably in the MDR variant.
- Rap1 silencing partially reversed etoposide resistance and TRF2-mediated resistance.
- Rap1 silencing restored ATM expression and phosphorylation, leading to increased phosphorylation of ATM targets like γH2AX and p53.
Conclusions:
- Rap1 interacts with TRF2 and significantly contributes to TRF2-mediated DNA damage response and etoposide resistance in gastric cancer.
- Rap1's function involves regulating ATM activation, thereby influencing cellular response to chemotherapy.
More Related Videos
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
The Ras Gene
Ras is a...
Nucleotide Excision Repair
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...

